[EN] TARGETED NOVEL TRIAZOLOTHIADIAZINE DERIVATIVES FOR THE TREATMENT OF LUNG CANCER [FR] NOUVEAUX DÉRIVÉS DE TRIAZOLOTHIADIAZINE CIBLÉS POUR LE TRAITEMENT DU CANCER DU POUMON
摘要:
Within the scope of the invention, 15 novel 3-[2-(1,3-benzodioxole-5-yl)ethyl)]-6-aryl-7H-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazine derivatives were synthesized. The cytotoxic and apoptotic effects of some synthesized compounds in human lung adenocarcinoma (A549) cells through the inhibition of cyclooxygenase-2 (COX-2), Akt and/or Rho-protein kinase (ROCK) enzymes were determined.